Question from Deputy Ken O'Flynn - PQ 15811-26
Deputy O'Flynn asked about the use of tirzepatide for type 2 diabetes mellitus and weight management. Read the HSE response.
- Published date:
- :
Corporate publications
Browse and read HSE's latest publications, which include strategic plans, reports, official policies and codes, Parliamentary Question (PQ) responses, and board meeting minutes.
Showing 4761 to 4770 of 7991 results
Question from Deputy Ken O'Flynn - PQ 15812-26
Deputy O'Flynn asked about the health technology assessments conducted in respect of tirzepatide. Read the HSE response.
- Published date:
- :
Question from Deputy Ken O'Flynn - PQ 15813-26
Deputy O'Flynn asked about the reimbursement of tirzepatide for weight management. Read the HSE response.
- Published date:
- :
Question from Deputy Ken O'Flynn - PQ 16016-26
Deputy O'Flynn asked about the average waiting time and the longest waiting time for a first outpatient appointment in a publicly funded chronic pain service.
- Published date:
- :
Question from Deputy Ken O'Flynn - PQ 16015-26
Deputy O'Flynn asked for the current hospital-by-hospital list of all publicly funded chronic pain management services. Read the HSE response.
- Published date:
- :
Question from Deputy Michael Murphy - PQ 15989-26
Deputy Murphy asked about number of persons under 18 admitted to adult psychiatric centres for the treatment of eating disorders in 2025. Read the HSE response.
- Published date:
- :
Question from Deputy Darren O'Rourke - PQ 16071-26
Deputy O'Rourke asked about the support for Clann Mór in Meath. Read the HSE response.
- Published date:
- :
Question from Deputy David Cullinane - PQ 16124-26
Deputy Cullinane asked about the funding allocated to developing a new adult mental health unit at UHW. Read the HSE response.
- Published date:
- :
Question from Deputy Peter Cleere - PQ 15961-26
Deputy Cleere asked about the number of ambulance bases in Carlow and Kilkenny. Read the HSE response.
- Published date:
- :
Question from Deputy Ken O'Flynn - PQ 15814-26
Deputy O'Flynn asked about the pharmacoeconomic evaluations of tirzepatide and semaglutide. Read the HSE response.
- Published date:
- :